Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 31 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-06-22 TVM Life Science Ventures VI GmbH & Co KG 10% owner Purchase · Series A Convertible Preferred Stock +372 $1,000.00 $372K 500
2017-06-22 TVM Life Science Ventures VI GmbH & Co KG 10% owner Purchase · Series A Convertible Preferred Stock +128 $1,000.00 $128K 500
2017-06-20 Kingsley Stuart A Director Grant or award · Stock Option (Right to Buy) +6,666 6,666
2017-06-20 HASTINGS PAUL J Director Grant or award · Stock Option (Right to Buy) +6,666 6,666
2017-06-20 Canute Scott A Director Grant or award · Stock Option (Right to Buy) +6,666 6,666
2017-06-20 BOHLIN GAREN G Director Grant or award · Stock Option (Right to Buy) +6,666 6,666
2017-06-20 Haines Timothy Director Grant or award · Stock Option (Right to Buy) +6,666 6,666
2017-06-20 Freund John Gordon Director Grant or award · Stock Option (Right to Buy) +6,666 6,666
2017-06-20 Birner Hubert Director Grant or award · Stock Option (Right to Buy) +6,666 6,666
2017-06-20 Abingworth LLP 10% owner Grant or award · Stock Option (Right to Buy) +6,666 6,666
2017-03-10 Burke Steven Keith SVP and Chief Medical Officer Exercise or conversion +12,287 $2.38 $29K 37,601
2017-03-10 Burke Steven Keith SVP and Chief Medical Officer Exercise or conversion +57,934 $1.27 $74K 95,535
2017-03-10 Burke Steven Keith SVP and Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) −12,287 0
2017-03-10 Burke Steven Keith SVP and Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) −57,934 0
2017-01-24 Toner E. Scott Senior VP of Marketing Grant or award · Stock Option (Right to Buy) +73,039 73,039
2017-01-24 NOYES TIMOTHY P President and CEO Grant or award · Stock Option (Right to Buy) +122,838 122,838
2017-01-24 Gottlieb Daniel Philip VP Corporate Development Grant or award · Stock Option (Right to Buy) +29,215 29,215
2017-01-24 Eldridge, George Arthur Snr VP,CFO,Treasurer,Asst Secy Grant or award · Stock Option (Right to Buy) +53,119 53,119
2017-01-24 Burke Steven Keith SVP and Chief Medical Officer Grant or award · Stock Option (Right to Buy) +53,119 53,119
2016-12-02 Burke Steven Keith SVP and Chief Medical Officer Gift −2,500 30,314

Page 22 of 24 · 473 trades